SARS-CoV-2, COVID-19, Infection Fatality Rate (IFR) Implied by the Serology, Antibody, Testing in New York City

22 Pages Posted: 11 May 2020 Last revised: 9 Nov 2023

See all articles by Linus Wilson

Linus Wilson

University of Louisiana at Lafayette - College of Business Administration

Date Written: November 6, 2023

Abstract

This paper estimates SARS-CoV-2, COVID-19, infection fatality rate (IFR) in early 2020 before pharmaceutical interventions were available on a large population in the United States. The better estimates of COVID-19 deaths in New York City and its high COVID-19 infection rate made it ideal to accurately estimate the IFR. We survey serology, antibody, studies of the COVID-19 infection to find official cases are understated by an average of 25-to-1. Further, we analyze the deaths and infections in New York City to estimate an overall IFR for the United States of 0.863 percent.

Note: Funding: We have received no funding to write this study.

Conflict of Interest: We have no conflicts of interest.

Keywords: antibody, CFR, COVID-19, death rates, IFR, New York City, SARS-CoV-2, serology, seroprevalance

JEL Classification: G22, I1, I18, J31, J65, K32

Suggested Citation

Wilson, Linus, SARS-CoV-2, COVID-19, Infection Fatality Rate (IFR) Implied by the Serology, Antibody, Testing in New York City (November 6, 2023). Available at SSRN: https://ssrn.com/abstract=3590771 or http://dx.doi.org/10.2139/ssrn.3590771

Linus Wilson (Contact Author)

University of Louisiana at Lafayette - College of Business Administration ( email )

Department of Economics & Finance
214 Hebrard Blvd., Room 326
Lafayette, LA 70504-0200
United States
(337) 482-6209 (Phone)
(337) 482-6675 (Fax)

HOME PAGE: http://www.linuswilson.com

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
3,379
Abstract Views
19,632
Rank
6,563
PlumX Metrics